Cargando…
Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges
COVID-19 oral treatments require initiation within 5 days of symptom onset. Although antigen tests are less sensitive than RT-PCR, rapid results could facilitate entry to treatment. We collected anterior nasal swabs for BinaxNOW and RT-PCR testing and clinical data at a walk-up, community site in Sa...
Autores principales: | Schrom, John, Marquez, Carina, Wang, Chung-Yu, Saxena, Aditi, Mitchell, Anthea M., Ribeiro, Salu, Pilarowski, Genay, Nakamura, Robert, Rojas, Susana, Black, Douglas, Contreras Oseguera, Maria G., Diaz, Edgar Castellanos, Payan, Joselin, Rojas, Susy, Jones, Diane, Tulier-Laiwa, Valerie, Zavaleta, Aleks, Martinez, Jacqueline, Chamie, Gabriel, Glaser, Carol, Jacobson, Kathy, Petersen, Maya, DeRisi, Joseph, Havlir, Diane V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038282/ https://www.ncbi.nlm.nih.gov/pubmed/36961855 http://dx.doi.org/10.1371/journal.pone.0283576 |
Ejemplares similares
-
Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing
por: Pilarowski, Genay, et al.
Publicado: (2020) -
COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods
por: Marquez, Carina, et al.
Publicado: (2022) -
High Parental Vaccine Motivation at a Neighborhood-Based Vaccine and Testing Site Serving a Predominantly Latinx Community
por: Naso, Jamie, et al.
Publicado: (2021) -
Integrating Rapid Diabetes Screening Into a Latinx Focused Community-Based Low-Barrier COVID-19 Testing Program
por: Kerkhoff, Andrew D., et al.
Publicado: (2022) -
High Likelihood of Accepting COVID-19 Vaccine in a Latinx Community at High SARS-CoV-2 Risk in San Francisco
por: Peng, James, et al.
Publicado: (2021)